AstraZeneca orders four more APAS Independence instruments
Drug manufacturer AstraZeneca has ordered four more APAS Independence laboratory instruments from AI microbiology automation manufacturer Clever Culture Systems, formally known as LBT Innovations. The order, worth $3.1 million over seven years, adds to the five APAS instruments already in use by the global pharmaceutical company, where they monitor for bacterial contamination in the company’s…